Global Ibuprofen Injection Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ibuprofen Injection Market Research Report 2024
Ibuprofen injection is a nonsteroidal antiinflammatory drug (NSAID) that is used alone or together with other medicines (eg, opioid analgesics) to relieve mild to severe pain. It is also used to treat fever. This medicine is to be given only by or under the supervision of your doctor.
According to Mr Accuracy reports new survey, global Ibuprofen Injection market is projected to reach US$ 9019.4 million in 2029, increasing from US$ 5670 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ibuprofen Injection market research.
Key manufacturers engaged in the Ibuprofen Injection industry include Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc., Alveda Pharmaceuticals (Teligent), Soho Industri Pharmasi, Grifols, Easton Biopharmaceuticals, Sihuan Pharmaceutical and Chengdu Brilliant Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ibuprofen Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ibuprofen Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ibuprofen Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cumberland Pharmaceuticals
CSL Limited
Akorn, Inc.
Alveda Pharmaceuticals (Teligent)
Soho Industri Pharmasi
Grifols
Easton Biopharmaceuticals
Sihuan Pharmaceutical
Chengdu Brilliant Pharmaceutical
Minsheng Pharmaceutical
Segment by Type
4ml0.4g
8ml0.8g
Hospitals
Clinics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ibuprofen Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Ibuprofen Injection market is projected to reach US$ 9019.4 million in 2029, increasing from US$ 5670 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ibuprofen Injection market research.
Key manufacturers engaged in the Ibuprofen Injection industry include Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc., Alveda Pharmaceuticals (Teligent), Soho Industri Pharmasi, Grifols, Easton Biopharmaceuticals, Sihuan Pharmaceutical and Chengdu Brilliant Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ibuprofen Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ibuprofen Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ibuprofen Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cumberland Pharmaceuticals
CSL Limited
Akorn, Inc.
Alveda Pharmaceuticals (Teligent)
Soho Industri Pharmasi
Grifols
Easton Biopharmaceuticals
Sihuan Pharmaceutical
Chengdu Brilliant Pharmaceutical
Minsheng Pharmaceutical
Segment by Type
4ml0.4g
8ml0.8g
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ibuprofen Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source